Discussion
Randomized surgical trials, especially those not supported by industry are notoriously few, hard to complete, and increasingly poorly supported by traditional granting agencies [Nonetheless, the COOL trial has been designed to answer a critical clinical question that faces clinicians worldwide on a daily basis for which there is important clinical equipoise and potential severe consequences for patients in regards to outcomes [As over-resuscitation becomes less common [